SAM
TEVA icon

Sectoral Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sectoral Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,120
Closed -$218K – 134
2018
Q3 		$218K Buy
+10,120
New +$235K 0.02% 130
2017
Q3 		– Sell
-602,279
Closed -$20M – 66
2017
Q2 		$20M Sell
602,279
-151,542
-20% -$4.69M 2.19% 19
2017
Q1 		$24.2M Buy
+753,821
New +$25.7M 2.83% 15
2016
Q4 		– Sell
-454,172
Closed -$20.9M – 61
2016
Q3 		$20.9M Sell
454,172
-161,763
-26% -$8.44M 2.05% 21
2016
Q2 		$30.9M Buy
615,935
+106,825
+21% +$5.69M 3.19% 13
2016
Q1 		$27.2M Sell
509,110
-96,812
-16% -$5.68M 1.32% 25
2015
Q4 		$39.8M Buy
605,922
+10,972
+2% +$678K 1.7% 18
2015
Q3 		$33.6M Buy
594,950
+235,118
+65% +$15.2M 1.54% 20
2015
Q2 		$21.3M Sell
359,832
-1,300,751
-78% -$80.2M 0.89% 35
2015
Q1 		$103M Buy
1,660,583
+279,695
+20% +$16.3M 3.93% 8
2014
Q4 		$79.4M Sell
1,380,888
-327,303
-19% -$18.2M 3.56% 7
2014
Q3 		$91.8M Buy
1,708,191
+195,604
+13% +$10.4M 3.86% 7
2014
Q2 		$79.3M Buy
1,512,587
+70,595
+5% +$3.61M 3.36% 7
2014
Q1 		$76.2M Buy
1,441,992
+828,343
+135% +$38.3M 3.13% 9
2013
Q4 		$24.6M Buy
613,649
+179,600
+41% +$7.07M 1.06% 35
2013
Q3 		$16.4M Buy
434,049
+26,300
+6% +$1.03M 0.79% 39
2013
Q2 		$16M Buy
+407,749
New +$15.9M 0.47% 42

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Sectoral Asset Management's TEVA Position: Q4 2018 in Review

Sectoral Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 10,120 shares — an estimated $218K sold.

Sectoral Asset Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $103M in Q1 2015. 552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • Sectoral Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Sectoral Asset Management sold 10,120 Teva Pharmaceuticals shares in Q4 2018, an estimated $218K.
  • Sectoral Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Sectoral Asset Management's Teva Pharmaceuticals position peaked at $103M in Q1 2015.
  • 552 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.